We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+12.3%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$1.91B
AUM Growth
+$117M
Cap. Flow
-$7.1M
Cap. Flow %
-0.37%
Top 10 Hldgs %
29.56%
Holding
333
New
49
Increased
56
Reduced
52
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 20.56%
2 Healthcare 16.67%
3 Consumer Discretionary 14.24%
4 Financials 13.38%
5 Miscellaneous 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QDEL icon
126
QuidelOrtho
QDEL
$729M
$3.37M 0.18%
+39,330
New +$3.33M
MAS icon
127
Masco
MAS
$13.6B
$3.35M 0.18%
71,800
PRVA icon
128
Privia Health
PRVA
$2.6B
$3.33M 0.17%
146,645
-23,660
-14% -$659K
KBH icon
129
KB Home
KBH
$3.04B
$3.32M 0.17%
+104,350
New +$3.11M
LPLA icon
130
LPL Financial
LPLA
$26.9B
$3.31M 0.17%
15,325
-24,460
-61% -$5.72M
AGYS icon
131
Agilysys
AGYS
$2.95B
$3.3M 0.17%
41,747
+5,000
+14% +$319K
BRBR icon
132
BellRing Brands
BRBR
$1.06B
$3.27M 0.17%
127,510
-117,400
-48% -$2.82M
ITCI
133
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.25M 0.17%
61,370
-26,810
-30% -$1.34M
VLO icon
134
Valero Energy
VLO
$114B
$3.13M 0.16%
24,690
MPC icon
135
Marathon Petroleum
MPC
$115B
$3.13M 0.16%
26,869
AMBA icon
136
Ambarella
AMBA
$2.84B
$3.12M 0.16%
+37,940
New +$2.53M
MXL icon
137
MaxLinear
MXL
$6.09B
$3.09M 0.16%
90,922
+1,470
+2% +$49.8K
XENE icon
138
Xenon Pharmaceuticals
XENE
$5.45B
$3.07M 0.16%
+77,740
New +$2.83M
PD icon
139
PagerDuty
PD
$1.14B
$3.03M 0.16%
+113,950
New +$2.69M
CVSA
140
Covista Inc
CVSA
$4.3B
$3M 0.16%
84,520
+1,310
+2% +$51.1K
EXTR icon
141
Extreme Networks
EXTR
$2.88B
$3M 0.16%
+163,860
New +$2.87M
WIX icon
142
WIX.com
WIX
$3.46B
$3M 0.16%
+39,040
New +$3.15M
EPD icon
143
Enterprise Products Partners
EPD
$83.8B
$2.98M 0.16%
123,691
PRCT icon
144
Procept Biorobotics
PRCT
$1.11B
$2.82M 0.15%
67,960
+1,060
+2% +$45.5K
PI icon
145
Impinj
PI
$5.33B
$2.78M 0.15%
+25,460
New +$2.68M
PTEN icon
146
Patterson-UTI
PTEN
$4.85B
$2.78M 0.15%
164,820
-729,390
-82% -$12M
COHR icon
147
Coherent
COHR
$53.1B
$2.77M 0.14%
+78,820
New +$2.74M
DCP
148
DELISTED
DCP Midstream, LP
DCP
$2.73M 0.14%
70,345
+9,890
+16% +$383K
DEN
149
DELISTED
Denbury Inc.
DEN
$2.69M 0.14%
+30,930
New +$2.81M
ACLS icon
150
Axcelis
ACLS
$3.24B
$2.65M 0.14%
33,350
+520
+2% +$36.6K

Similar funds

Castleark Management's Q4 2022 Portfolio in Review

As of Q4 2022, Castleark Management held 333 positions worth $1.91B, up 6.5% from $1.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Castleark Management's Q4 2022 filing shows 49 new, 56 increased, 52 reduced and 51 closed positions. Its largest new stake was iShares MSCI Japan ETF: 445,300 shares worth $24.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $44.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Castleark Management's largest Q4 2022 buy was iShares MSCI Japan ETF: 445,300 shares worth $24.2M.
  • Castleark Management added most to iShares MSCI Emerging Markets ETF in Q4 2022, an estimated $38.3M increase.
  • Castleark Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $25.4M.
  • Castleark Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2022, selling an estimated $44.6M.
  • Castleark Management's ten largest holdings make up 30% of its $1.91B portfolio in Q4 2022.
  • Castleark Management opened 49 new positions and closed 51 in Q4 2022.
  • Castleark Management's portfolio value rose 6.5% quarter-over-quarter to $1.91B.

Based on Castleark Management's 13F filing for Q4 2022, filed 10 Feb 2023.